{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Sanofi", "item": "https://www.patentleaderboard.com/company/sanofi"}, {"@type": "ListItem", "position": 3, "name": "Ang\u00e8le Moryusef", "item": "https://www.patentleaderboard.com/inventor/fl:an_ln:moryusef-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sanofi › Angèle Moryusef
AM

Angèle Moryusef — 2 Patents

SASanofi: 2 patents #699 of 1,881Top 40%
Bound Brook, NJ: #662 of 1,249 inventorsTop 55%
New Jersey: #30,063 of 69,400 inventorsTop 45%
Overall (All Time): #1,709,992 of 4,157,543Top 45%
2 Patents All Time
Angèle Moryusef has been granted 2 US patents while listed as an inventor at Sanofi. The first was granted in 2016 and the most recent in March 2017. Angèle Moryusef ranks #1,709,992 of 4,157,543 US inventors in our database (top 41.1%). Patent records list Angèle Moryusef in Bound Brook, NJ, US.

Issued Patents All Time

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
9597322 Otamixaban for use in the treatment of non-ST elevation acute coronary syndrome in patients planned to undergo coronary artery bypass grafting Christophe GAUDIN 2017-03-21 $7,741,000
9492437 Otamixaban for treatment of elderly and renal impaired non-ST elevation myocardial infarction patients Jens Stechl, Christophe GAUDIN, Pascale Ythier-Moury 2016-11-15 $4,640,000

Frequent Collaborators

Christophe GAUDIN2 shared
Jens Stechl1 shared
Pascale Ythier-Moury1 shared

Nearby-Ranked Inventors

Leonard Mattheis2
Yiqi SHI2
Roberto DiCecco2
Haoneng Xu2
Emily Chew2
So Young Bae2
Julian Alexander Georgi2
Yoshihiro Asahara2
Assaf Ariel2